← Back to Search

Nutritional Therapy

Vegetarian Keto Diet for Type 2 Diabetes (DT2-OFF Trial)

N/A

Waitlist Available

Research Sponsored by BloomedIn

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 90 min after each meal, during the first 2 months and the last 2 months

Awards & highlights

DT2-OFF Trial Summary

This trial will examine if a vegan diet can help type 2 diabetics better manage their blood sugar. It will also look at the role of the gut microbiome in metabolic diseases.

Who is the study for?

This trial is for adults aged 18 to 70 with Type 2 diabetes who are currently on medication for their condition. It's not suitable for those with abnormal C-peptide levels, Type 1 diabetes, anyone already on a ketogenic or vegan diet for over a month, or pregnant/breastfeeding women.Check my eligibility

What is being tested?

The study compares the effects of two types of ketogenic diets on Type 2 diabetes management: one vegetarian and one omnivore. It will explore how these diets impact blood sugar control and gut microbes by analyzing participants' microbiome and daily breath tests.See study design

What are the potential side effects?

Potential side effects may include digestive changes due to diet alteration, possible nutrient deficiencies if the diet isn't well-planned, and initial symptoms like fatigue or irritability as the body adapts to ketosis.

DT2-OFF Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 90 min after each meal, during the first 2 months and the last 2 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~90 min after each meal, during the first 2 months and the last 2 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 min after each meal, during the first 2 months and the last 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline CRP

Change from baseline HbA1c

Insulin

+1 more

Secondary outcome measures

Gallium

Body Weight Changes

DT2-OFF Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Vegetarian ketogenic dietExperimental Treatment1 Intervention

Participants will be required to eat a diet that is very low in carbohydrates, moderate in vegetarian proteins, including fish and eggs, with added healthy fats

Group II: Omnivor ketogenic dietActive Control1 Intervention

Participants will be required to eat a diet that is very low in carbohydrates, moderate in animal protein, with added healthy fats.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

BloomedInLead Sponsor

Institut universitaire de cardiologie et de pneumologie de Québec, University LavalOTHER

18 Previous Clinical Trials

3,464 Total Patients Enrolled

1 Trials studying Diabetes Mellitus

150 Patients Enrolled for Diabetes Mellitus

Institut universitaire de cardiologie et de pneumologie de QuébecUNKNOWN

3 Previous Clinical Trials

1,969 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the eligibility criterion of this trial encompass individuals that are over 25 years old?

"This research endeavour is enrolling adults aged between 18 and 70."

Answered by AI

Are there slots still available for prospective participants in this research program?

"As found on clinicaltrials.gov, this study is not currently enrolling participants; the original posting date was May 11th 2022 and there has been no updates since October 13th 2022. Nonetheless, 2472 other trials are actively seeking patients for their studies."

Answered by AI

Is my eligibility within the parameters of this clinical experiment?

"This research initiative is looking for 19 participants with hypertension who are aged between eighteen and seventy. The applicants must also have been diagnosed with Type 2 diabetes, be under medical treatment for the condition, and fit within the aforementioned age range."

Answered by AI